New advance in COPD maintenance treatment, Spiolto® Respimat®, approved in first European countries

Med Career News Medical TidbitsSubscribe today for leading medical news and career advice from top medical recruiters!

Ingelheim, Germany, 2nd July, 2015 — Boehringer Ingelheim today announced regulatory authority approvals for Spiolto® Respimat® (tiotropium/olodaterol) in first European countries†. Spiolto® Respimat® is a once-daily maintenance treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). Approvals of the treatment in other European countries are expected to follow in the coming months. Spiolto® Respimat® provides significant improvements in lung function, breathlessness, quality of life and rescue medication use over Spiriva® right from the initial stages when patients need maintenance therapy.1 These additional benefits could enable patients to remain active and avoid the downward spiral of COPD for as long as possible.

The journal PLOS Neglected Tropical Diseases published today the results of a trial of Oxitec’s genetically engineered mosquitoes. The results showed that in Juazeiro city, northeast Brazil, the Oxitec mosquito successfully controlled the Aedes aegypti mosquito that spreads dengue fever, chikungunya and zika virus, by reducing the target population by more than 90%. Popularly known in Brazil as “Friendly Aedes aegypti“, the Oxitec mosquito decreased the population of the dengue mosquito so low that it would not support epidemic disease transmission according to mathematical models[1].

Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda TeRedwood Pharma AB has entered into a licensing agreement with Broda Technologies Co., Ltd., operating in both the US and China, to use the company’s proprietary IntelliGel® supramolecular hydrogel technology in its lead chronic Dry Eye therapeutic currently under development and other ophthalmic therapies

Patient Treated at SIM’s ELWA Ebola Care Center in Monrovia; Organization Prepares for Possibility of More as One-Year Anniversary of Infected Americans Approaches

CHARLOTTE, N.C., July 2, 2015 /PRNewswire/ — After 45 days of no new Ebola cases, Liberian health officials had declared the country Ebola-free in May. Now there are a number of new Ebola cases reported in that country, one of whom is being treated in the Ebola Treatment Center at SIM’s ELWA campus in Monrovia. read more

 

Get Med Career News in your Inbox!

If you want to keep up with the latest news and career tips in the Medical Field subscribe today!

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.